Issa Sabi

Dr Issa Sabi, MD, MMed is a Peadiatrician and research scientist at NIMR and works as sub investigator for the PROTID project.

Dr Sabi is the Head for the Department of Tuberculosis and Emerging diseases at NIMR-MMRC supporting various TB and HIV research projects ranging from drug trials, vaccine trials, diagnostics studies, and observational studies. He has over 9 years experience in National and multinational research projects.

His current work focuses on evaluation of new TB diagnostics in children including his recently published work on evaluation of Xpert MTB/RIF Ultra assay for the diagnosis of TB in Children. Recent work includes PMTCT interventions and the evaluation of Point of Care (PoC) tests for HIV early infant Diagnosis. In addition to his work for the PROTID project, dr. Sabi supports the EDCTP funded project (LIFE study) which evaluates if HIV testing at birth (using PoC tests) followed by immediate neonatal HIV treatment initiation leads to lesser infant sickness, HIV progression or even death as compared to the current standard of care.

Dr Sabi is a member of the Childhood TB Technical Working Group in Tanzania; a member of National TB operational research coordinating committee; and a member of Paediatric Association of Tanzania (PAT). He received his Medical Degree from Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Master of Medicine degree from the Catholic University of Health and Allied Sciences, Mwanza, Tanzania and currently holds a PhD position at the CIHLMU Centre for International Health at the University of Munich, Germany